Sehgal, Alison
UPMC Hillman Cancer Center
2 papers on CoChatORCID 0000-0003-3954-7401
Most cited papers
- Verified
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 2,430
- Verified
Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium
Nastoupil, L. J., Jain, M. D., Feng, L., Spiegel, J. Y., Ghobadi, A., Lin, Y., Dahiya, S., Lunning, M., Lekakis, L., Reagan, P., et al. (2020) · Journal of Clinical Oncology
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 801
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free